About iScience Interventional
iScience Interventional is a company based in Menlo Park (United States) founded in 1999 was acquired by Ellex in January 2014. iScience Interventional has raised $36.68 million across 7 funding rounds from investors including Medtronic, Square 1 Bank and Indiana University Health. iScience Interventional operates in a competitive market with competitors including Kodiak Sciences, Pixium Vision, Second Sight, Eyedaptic and Medical Instrument Development Laboratories, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iscience Interventional Corp
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iScience Interventional
iScience Interventional has successfully raised a total of $36.68M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5 million completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iScience Interventional
iScience Interventional has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Square 1 Bank and Indiana University Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for iScience Interventional
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iScience Interventional
Investment portfolio details for iScience Interventional
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iScience Interventional
Detailed financials for iScience Interventional
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iscience Interventional Comparisons
Peer comparison for iScience Interventional
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iScience Interventional
iScience Interventional operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kodiak Sciences, Pixium Vision, Second Sight, Eyedaptic and Medical Instrument Development Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for retinal diseases are developed by the company.
|
|
| Locked | Locked | Locked |
Bionic vision restoration systems are provided for sight restoration.
|
|
| Locked | Locked | Locked |
Implantable visual prosthetics for blind individuals are developed and provided.
|
|
| Locked | Locked | Locked |
A wearable augmented reality vision assistance solution
|
|
| Locked | Locked | Locked |
Develops ophthalmic products for ophthalmic system manufacturers
|
Detailed competitors of iScience Interventional
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iscience Interventional
Complete news archive for iScience Interventional
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iScience Interventional
iScience Interventional was founded in 1999 and raised its 1st funding round 10 years after it was founded.
iScience Interventional is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
iScience Interventional is a funded company, having raised a total of $36.68M across 7 funding rounds to date.
iScience Interventional was founded in 1999 in Menlo Park, United States, focusing on medical devices for ophthalmology. Microcatheter, microcannula, and imaging technologies were developed, including the iTRACK microcatheter, ViscoInjector for canaloplasty, iLumin portable laser diode light source, and iUltraSound imaging product. Operations centered on tools for ophthalmologists until acquisition by Ellex in 2014.
iScience Interventional's top competitors include Kodiak Sciences, Second Sight and Pykus Therapeutics.
iScience Interventional has 11 investors. Key investors include Medtronic, Square 1 Bank, Indiana University Health, Ellex, and Affinity Capital Management.